🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07262307
Active, not recruiting Not applicable

Evaluation of PEEK Versus Titanium Bar Attachments With Implant Assisted Mandibular Complete Overdenture Fabricated by CAD/CAM Technology

NCT07262307 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2024-05-30
Last updated
2025-12-03

Condition(s) studied

Edentulism in Lower Jaw

Investigational drug(s) / intervention(s)

implant overdenture

implant overdenture: using of CAD/CAM with new material and digital fabrication techniques

Study summary

Evaluation of PEEK versus Titanium Bar Attachments with Implant Assisted Mandibular Complete Overdenture fabricated by CAD/CAM Technology measuring retention of the overdenture and implant evaluation for 6 months and one year

Eligibility

Sex
MALE
Min age
45 Years
Max age
60 Years
Healthy volunteers
Accepted
Inclusion Criteria: * • Completely edentulous patients free from systemic diseases that may affect soft or hard tissue healing. * Patient's age ranges from 40 to 60 years old. * The bone quality and quantity of the mandibular alveolar ridge must fulfill the criteria for implant placement. * They have normal class Ӏ maxilla-mandibular relationship and sufficient inter-arch space with at least 25mm for bar attachment. * They have good oral hygiene. Exclusion Criteria: * Systemic disorders that may influence soft or hard tissue healing as oral diseases. * Patients with history of radiation therapy in the head and neck region. * Patients with neurological or psychological problems that may impair good oral hygiene.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Faculty of Dentistry Tanta Elgharbiy

More Tanta University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07262307 on ClinicalTrials.gov ↗ ← All trials in Egypt